Dogwood Therapeutics Inc DWTX 深 滬
等待開盤 07-31 09:30:00 美东时间
1.58
+0.040
+2.60%
華盛通- 最 高1.62
- 今 開1.52
- 成交量 8401股
- 最 低 1.47
- 昨 收 1.54
- 總市值 5313.47万
- 52周最高 9.50
- 市盈率 靜 --
- 換手率 0.02%
- 52周最低 1.28
- 委 比 26.50%
- 總股本 3362.96万
- 歷史最高 417.75
- 量 比 0.25
- 振 幅 9.74%
- 歷史最低 1.28
- 每 手 1
- 風險率 1.83%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Dogwood Therapeutics Starts New Halneuron Hemotherapy Induced Neuropathic Pain Phase 2b Extension Trial
Dogwood Therapeutics, Inc. (NASDAQ:DWTX) ("Dogwood" or the "Company"), a biopharmaceutical company developing first-in-class, non-opioid medicines to treat pain and neuropathy, today announced commencement of a new
05-18 20:48
Dogwood Therapeutics Q1 EPS $(0.15), Inline
Dogwood Therapeutics (NASDAQ:DWTX) reported quarterly losses of $(0.15) per share which met the analyst consensus estimate. This is a 98.22 percent increase over losses of $(8.45) per share from the same period last
05-14 20:31
Earnings Scheduled For May 14, 2026
Companies Reporting Before The Bell • Urban One (NASDAQ:UONEK) is expected to r...
05-14 19:11
美股大行评级 | 美银大幅上调西部数据、希捷科技目标价！宝洁、Baker Hughes、Flagstar Bank、斯伦贝谢等获多家大行上调目标价
今日重点评级关注：Ascendiant Capital：维持NRX Pharmaceuticals"买入"评级，目标价从48美元升至49美元；Chardan Capital：维持Intellia Therapeutics"买入"评级，目标价从27美元升至30美元
04-28 10:07
Dogwood Therapeutics Partners With PRIDCor Therapeutics To Advance Its Anti-Viral Candidates IMC-1 And IMC-2
Dogwood Therapeutics, Inc. (NASDAQ:DWTX) ("Dogwood" or the "Company"), a company that focuses on developing new medicines to treat pain and neuropathy, today announced a global development and commercialization
04-23 21:07
